Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Medica Sur Clinical Foundation. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2021

See more
Impact factor 2020

CiteScore measures average citations received per document published.

See more
Citescore 2019

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2019

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2019
View more metrics
Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Direct-acting antiviral agents and risk of Hepatocellular carcinoma: critical appraisal of the evidence
Ciro Celsa, Caterina Stornello, Paolo Giuffrida, Carmelo Marco Giacchetto, Mauro Grova, Gabriele Rancatore, Concetta Pitrone, Vito Di Marco, Calogero Cammà, Giuseppe Cabibbo
Open access
miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR
Wei Tan, Zhuokai Li, Weifen Xia, Jinde Zhu, Rengen Fan
Open access
View all Ahead of print
Current Issue
Vol. 24.
(September - October 2021)
Editorial Board
Ann Hepatol. 2021;24C:100529
Open access
Annals of Hepatology: the journal we dreamed of
Octavio Campollo
Ann Hepatol. 2021;24C:100524
Open access
NAFLD: Challenges and opportunities to address the public health problem in Latin America
Juan Pablo Arab, Luis Antonio Díaz, Melisa Dirchwolf, Henry E. Mark, Jeffrey V. Lazarus, Elly Vaughan, Nahum Méndez-Sánchez, Claudia P. Oliveira, Adrián Gadano, Marco Arrese
Ann Hepatol. 2021;24C:100359
Open access
View all issue
Issues in progress
View all issues in progress
View all archive
View all supplements
Most Often Read
Original article
Ashish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, Nagaraj-Sanchitha Honganur, Aelia Akbar, Aran Deol, Benedict Francis, Shakumar Patel, Deep Mehta, Richa Jaiswal, Jagmeet Singh, Urvish Patel, Preeti Malik
Ann Hepatol. 2021;21C:
This article has been read 5.480 times
View all Most Often read articles
Instructions for authors
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos